Biotechnological businesses are the use of living organisms for commercial purposes. The major area of biotechnology is medicine and related products such as vaccines. Biotechnology is used in heavy industry, agriculture and mining with products such as biopesticides. Many pharmaceutical companies have a distinct division for biotech-based medicines. Certain of these medicines are derived from living organisms, whereas others have a chemical basis. This distinction is important because the risk profiles of these two industries are different.

A biotech company is expensive to operate due to its extensive research and development. A successful drug could yield significant returns on investment. But it can take years for a new product be available for sale. The FDA approval process is long and complicated. It requires preclinical testing as well as www.genotec-frankfurt.de/top-5-simple-virtual-deal-software-for-beginners/ clinical trials and quality control. According to Science Daily, only a small percentage of the compounds that are tested ultimately are released to the market.

Biotech companies have the option to focus their efforts on technology partnerships or create their own pharmaceutical assets that they license to large pharmaceutical companies to manufacture and sell. Many young biotechs opt for the latter option since it could boost revenue growth. However, it is not without risk, as they have to also pay for the costs of developing clinical products and regulatory approval, as well as negotiations for reimbursement of insurance and sales promotion. Many biotech companies make strategic alliances to reduce these risks. These include partnerships with large pharmaceutical companies and smaller biotechnology platforms. Massachusetts’ biotech ecosystem, for example, includes a renowned universities, teaching hospitals, entrepreneur and venture capital communities.